Skip to content
  • Home
  • How We Work
    • The Impact of Autophagy in Health and Disease
    • Biophagy’s Business Model
    • Biophagy’s Proprietary Drug Development
    • Cell Watchᵀᴹ
  • Business Development
  • Background & News
  • Team
  • Contact
Previous Next

Biophagy announces the addition of Ian Henderson, PhD, as its head of medicinal chemistry

By jordan|2022-02-01T19:09:25+00:00February 1, 2022|2017-announcements|0 Comments

Share This Story, Choose Your Platform!

FacebookTwitterRedditLinkedInWhatsAppTelegramTumblrPinterestVkXingEmail

About the Author: jordan

Related Posts

  • Biophagy, working with Sandia National Laboratories, is awarded an individual company grant from NMSBA to study the relative potencies and binding sites of several autophagy stimulant combinations.

    Biophagy, working with Sandia National Laboratories, is awarded an individual company grant from NMSBA to study the relative potencies and binding sites of several autophagy stimulant combinations.

Leave A Comment Cancel reply

Copyright 2022 | All Rights Reserved | Website Design and Development by Ingenuity Software Labs
FacebookTwitterInstagramPinterest
Page load link
Go to Top